The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

WuXi AppTec, a global contract research, development, and manufacturing organization (CRDMO), recently hosted its 2025 ...

Teva Pharmaceuticals USA and Amerisource Health Services issued voluntary nationwide recalls of various strengths of ...

Food and Drug Administration has warned four companies that it plans to take enforcement action over their sale of unapproved ...

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

The U.S. Food and Drug Administration (FDA) announced that more than 580,000 bottles of the blood pressure medication ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs.  The ...

At this month’s Food and Nutrition Conference and Expo in Nashville, one buzzword dominated conversations – GLP-1 medications ...

The ligament in your elbow that connects the bone in your upper arm to the one in your forearm is only about as strong as “a ...

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes ...